About ImmunXperts
ImmunXperts is a company based in Charleroi (Belgium) founded in 2014 was acquired by Nexelis in March 2020.. ImmunXperts has raised $1 million across 2 funding rounds from investors including Biowin, Nexelis and Sambrinvest. The company has 22 employees as of December 31, 2022. ImmunXperts offers products and services including Central Laboratories, Genomics, Discovery Sciences, and Biosciences. ImmunXperts operates in a competitive market with competitors including BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
- Headquarter Charleroi, Belgium
- Employees 22 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Immunxperts
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ImmunXperts
ImmunXperts offers a comprehensive portfolio of products and services, including Central Laboratories, Genomics, Discovery Sciences, and Biosciences. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides clinical trial testing and sample management for drug development.
Offers genomic testing to support precision medicine and research.
Delivers protein and antibody discovery for pharmaceutical applications.
Conducts bioanalytical assays for small and large molecules in drug testing.
Funding Insights of ImmunXperts
ImmunXperts has successfully raised a total of $1M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(16 Dec 2014)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2016 | Amount | Grant - ImmunXperts | Valuation |
investors |
|
| Dec, 2014 | Amount | Seed - ImmunXperts | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ImmunXperts
ImmunXperts has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Biowin, Nexelis and Sambrinvest. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC & PE fund
|
Founded Year | Domain | Location | |
|
Business development services for medical device manufacturing are provided.
|
Founded Year | Domain | Location | |
|
Assay development and bioanalytical services are provided worldwide.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ImmunXperts
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ImmunXperts
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Immunxperts Comparisons
Competitors of ImmunXperts
ImmunXperts operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| domain | founded_year | HQ Location |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| domain | founded_year | HQ Location |
Analytical and quality assurance services are provided for diverse industries.
|
|
| domain | founded_year | HQ Location |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| domain | founded_year | HQ Location |
Bioanalytical assays for drug development are developed and validated.
|
|
| domain | founded_year | HQ Location |
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about ImmunXperts
When was ImmunXperts founded?
ImmunXperts was founded in 2014.
Where is ImmunXperts located?
ImmunXperts is headquartered in Charleroi, Belgium. It is registered at Charleroi, Walloon Region, Belgium.
Is ImmunXperts a funded company?
ImmunXperts is a funded company, having raised a total of $1M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Dec 16, 2014.
How many employees does ImmunXperts have?
As of Dec 31, 2022, the latest employee count at ImmunXperts is 22.
What does ImmunXperts do?
ImmunXperts is a CRO engaged in the development of bioassays which involve the human immune system for drug development (biopharmaceutical, biosimilar and vaccines) applications. Their applications include immunogenicity of biotherapeutics (in vitro, in silico, in vivo and clinical services and regulatory support), and immuno-oncology (MLR Assays, Antigen-specific T cell activation and macrophage polarisation assays) and cell therapy (custom assays) development. They also offer services for the development of functional potency assays in the field of stem cell therapy. The company has received 1.6 million euro grant, along with other institutes and companies, to identify innovative drug candidates and biomarkers for immunotherapy of various types of cancer.
Who are the top competitors of ImmunXperts?
ImmunXperts's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
What products or services does ImmunXperts offer?
ImmunXperts offers Central Laboratories, Genomics, Discovery Sciences, and Biosciences.
Who are ImmunXperts's investors?
ImmunXperts has 3 investors. Key investors include Biowin, Nexelis, and Sambrinvest.